ULTUPHARMA AB has a total of 21 patent applications. It decreased the IP activity by 66.0%. Its first patent ever was published in 2015. It filed its patents most often in Sweden, United States and Australia. Its main competitors in its focus markets pharmaceuticals, environmental technology and organic fine chemistry are BCN BIOSCIENCES L L C, CALIXA THERAPEUTICS INC and HUANG YONGHUA.
# | Country | Total Patents | |
---|---|---|---|
#1 | Sweden | 4 | |
#2 | United States | 4 | |
#3 | Australia | 3 | |
#4 | Canada | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 3 | |
#6 | China | 2 | |
#7 | EPO (European Patent Office) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology | |
#3 | Organic fine chemistry | |
#4 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Climate change adaptation technologies | |
#4 | Heterocyclic compounds | |
#5 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Levenfors Jolanta | 18 |
#2 | Broberg Anders | 18 |
#3 | Bjerketorp Joakim | 18 |
#4 | Nord Christina | 11 |
#5 | Guss Bengt | 11 |
#6 | Sahlberg Christer | 7 |
#7 | Öberg Bo | 7 |
#8 | Andersson Pierre | 7 |
#9 | Joakim Bjerketorp | 3 |
#10 | Jolanta Levenfors | 3 |
Publication | Filing date | Title |
---|---|---|
AU2019329130A1 | Peptide compounds | |
SE1851022A1 | Cyclic peptides | |
SE1650097A1 | New method of treating bacterial infections | |
SE1551572A1 | Compounds and methods of treating bacterial infections |